Singular Historical Cash Flow

Stocks . Australia . 
Stock . Singular Health Group
SHG Stock   0.24  0.01  4.00%   
Analysis of Singular Health cash flow over time is an excellent tool to project Singular Health Group future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 222.1 K or Other Non Cash Items of 722.7 K as it is a great indicator of Singular Health ability to facilitate future growth, repay debt on time or pay out dividends.
   Cash Flow   Balance Sheet   Income Statement
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Singular Health Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Singular Health Group is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Singular Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Singular Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Singular balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Singular's non-liquid assets can be easily converted into cash.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details

Singular Health Cash Flow Chart

At this time, Singular Health's Sale Purchase Of Stock is comparatively stable compared to the past year. Change In Cash is likely to gain to about 721.7 K in 2025, whereas Free Cash Flow is likely to drop (2.4 M) in 2025.
Begin Period Cash Flow  Other Non Cash Items  Capital Expenditures  Change To Operating Activities  
Add Fundamental

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Singular Health Group to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Singular Health operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Singular Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Singular Health Group current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Singular Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Singular Health's Sale Purchase Of Stock is comparatively stable compared to the past year. Change In Cash is likely to gain to about 721.7 K in 2025, whereas Free Cash Flow is likely to drop (2.4 M) in 2025.
 2022 2023 2024 2025 (projected)
Other Non Cash Items2.8M661.5K760.7K722.7K
Depreciation389.1K197.7K227.3K222.1K

Singular Health cash flow statement Correlations

Sale Purchase Of Stock
Investments
Change In Cash
Net Borrowings
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Depreciation
Other Non Cash Items
Capital Expenditures
Change To Account Receivables
Change To Operating Activities
Net Income
End Period Cash Flow
Change To Netincome
Change To Liabilities
Stock Based Compensation
Issuance Of Capital Stock
Change To Inventory
Sale Purchase Of Stock
-0.070.830.46-0.440.16-0.090.280.440.070.72-0.19-0.460.930.510.12-0.060.010.11
Investments
-0.07-0.11-0.08-0.38-0.880.430.1-0.04-0.350.46-0.3-0.10.210.40.260.56-0.050.53
Change In Cash
0.83-0.110.540.03-0.07-0.59-0.16-0.130.450.38-0.030.090.630.040.1-0.510.50.13
Net Borrowings
0.46-0.080.54-0.31-0.06-0.320.410.03-0.270.0-0.7-0.140.330.320.75-0.120.020.49
Free Cash Flow
-0.44-0.380.03-0.310.02-0.75-0.92-0.830.84-0.650.740.92-0.66-0.99-0.55-0.830.77-0.39
Change In Working Capital
0.16-0.88-0.07-0.060.020.020.220.480.05-0.150.2-0.330.01-0.04-0.29-0.15-0.33-0.51
Begin Period Cash Flow
-0.090.43-0.59-0.32-0.750.020.680.76-0.780.46-0.35-0.780.230.730.130.96-0.850.17
Depreciation
0.280.1-0.160.41-0.920.220.680.82-0.910.34-0.82-0.890.430.880.660.76-0.890.38
Other Non Cash Items
0.44-0.04-0.130.03-0.830.480.760.82-0.640.6-0.36-0.980.60.830.120.69-0.820.02
Capital Expenditures
0.07-0.350.45-0.270.840.05-0.78-0.91-0.64-0.190.820.74-0.16-0.79-0.67-0.880.86-0.43
Change To Account Receivables
0.720.460.380.0-0.65-0.150.460.340.6-0.19-0.12-0.640.910.73-0.050.46-0.210.19
Change To Operating Activities
-0.19-0.3-0.03-0.70.740.2-0.35-0.82-0.360.82-0.120.52-0.28-0.7-0.96-0.550.57-0.62
Net Income
-0.46-0.10.09-0.140.92-0.33-0.78-0.89-0.980.74-0.640.52-0.65-0.92-0.29-0.760.84-0.14
End Period Cash Flow
0.930.210.630.33-0.660.010.230.430.6-0.160.91-0.28-0.650.730.140.26-0.170.2
Change To Netincome
0.510.40.040.32-0.99-0.040.730.880.83-0.790.73-0.7-0.920.730.50.81-0.720.45
Change To Liabilities
0.120.260.10.75-0.55-0.290.130.660.12-0.67-0.05-0.96-0.290.140.50.37-0.40.68
Stock Based Compensation
-0.060.56-0.51-0.12-0.83-0.150.960.760.69-0.880.46-0.55-0.760.260.810.37-0.850.38
Issuance Of Capital Stock
0.01-0.050.50.020.77-0.33-0.85-0.89-0.820.86-0.210.570.84-0.17-0.72-0.4-0.85-0.19
Change To Inventory
0.110.530.130.49-0.39-0.510.170.380.02-0.430.19-0.62-0.140.20.450.680.38-0.19
Click cells to compare fundamentals

Singular Health Account Relationship Matchups

High Positive Relationship

Stock Based Compensation
+ 0.96
Begin Period Cash Flow
End Period Cash Flow
+ 0.93
Sale Purchase Of Stock
Net Income
+ 0.92
Free Cash Flow
End Period Cash Flow
+ 0.91
Change To Account Receivables
Change To Netincome
+ 0.88
Depreciation
Issuance Of Capital Stock
+ 0.86
Capital Expenditures

High Negative Relationship

Change To Netincome
- 0.99
Free Cash Flow
Net Income
- 0.98
Other Non Cash Items
Change To Liabilities
- 0.96
Change To Operating Activities
Change To Netincome
- 0.92
Net Income
Depreciation
- 0.92
Free Cash Flow
Capital Expenditures
- 0.91
Depreciation

Singular Health cash flow statement Accounts

202020212022202320242025 (projected)
Investments(300K)(5.3K)(626.9K)(3.6K)(4.1K)(4.3K)
Change In Cash4.0M(3.0M)(448.4K)763.7K687.4K721.7K
Free Cash Flow(2.2M)(2.9M)(2.5M)(2.5M)(2.3M)(2.4M)
Change In Working Capital222.4K96.7K594.6K(223.3K)(201.0K)(190.9K)
Begin Period Cash Flow130.6K4.1M1.1M691.5K795.2K1.3M
Other Cashflows From Financing Activities(44.4K)(68.8K)(123.1K)(289.8K)(260.8K)(247.7K)
Depreciation130.7K259.8K389.1K197.7K227.3K222.1K
Other Non Cash Items2.3M3.2M2.8M661.5K760.7K722.7K
Capital Expenditures310.6K11.8K22.5K73.6K66.2K108.4K
Total Cash From Operating Activities(1.9M)(2.9M)(2.5M)(2.4M)(2.2M)(2.3M)
Change To Account Receivables149.5K69.6K(101.8K)(4.4K)(4.0K)(3.8K)
Net Income(4.5M)(6.0M)(5.4M)(2.9M)(2.6M)(2.7M)
Total Cash From Financing Activities6.5M(69.3K)2.7M3.2M3.7M2.9M
End Period Cash Flow4.1M1.1M691.5K1.5M1.3M1.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Singular Stock Analysis

When running Singular Health's price analysis, check to measure Singular Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Health is operating at the current time. Most of Singular Health's value examination focuses on studying past and present price action to predict the probability of Singular Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Health's price. Additionally, you may evaluate how the addition of Singular Health to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY